The potential relationship between GLP-1 receptor agonists like semaglutide and thyroid C-cell tumors has been observed in rodent studies, where dose-dependent and duration-dependent increases in thyroid C-cell tumors were noted
Others protect your teeth from the damage that dry mouth enables
Its most commonly used for patients who might have an allergy to an ingredient in a name-brand product or need it in a different form, like a liquid instead of a pill
It helps with weight loss and supports metabolic health, making it ideal for those with a BMI of 30 or higher, or a BMI of 27 with obesity-related conditions like high blood pressure, high cholesterol, prediabetes, or type 2 diabetes
Tirzepatide (Mounjaro/Zepbound) is a dual GLP-1/GIP agonist that produces weight loss results between semaglutide and retatrutide, with approximately 20-22% average weight loss at the 15 mg dose